Reflections on the changing face of german pharmaceutical policy: How far is Germany from value-based pricing?

PharmacoEconomics

Volumn 29, Issue 7, 2011, Pages 549-553

  Gerber, Andreas ^a   Stock, Stephanie ^b   Dintsios, Charalabos Markos ^a  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^b Institute of Health Economics and Clinical Epidemiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; INSULIN DERIVATIVE;

DRUG COST; DRUG MANUFACTURE; DRUG MARKETING; GERMANY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL;

DRUG COSTS; GERMANY; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; PHARMACEUTICAL PREPARATIONS; RATE SETTING AND REVIEW; REIMBURSEMENT MECHANISMS;

EID: 79959273192     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11592580-000000000-00000     Document Type: Note

References (20)

1. German Federal Minister of Health. Act to Reorganize the Pharmaceuticals- Market in the SHI System (Arzneimittelneuordnungsgesetz- AMNOG). 2010 Dec 22 [in German]. Bundesgesetzblatt 2010; Teil 1 (67): 2262-77 [online]. Available from URL: http://www.dkgev.de/media/ file/8847.RS003-11-Anlage1-Inkrafttreten- GKV-Finanzier ungsgesetz-und-Arzneimittelmarktneuordnungsgesetz.pdf [Accessed 2011 May 3]
2. German Federal (Social) Insurance Office. Declaration/ official statement by the Contributions/Levies Appraisal Committee of the SHI Funds, 6 October 2009 [online]. Available from URL: http://www.bundesversicherun gsamt.de/cln-115/nn-1047250/DE/Presse/Archiv-Down loads/PE-06.10.2009, templateId=raw,property=publicationFile.pdf/PE-06.pdf [Accessed 2011 Feb 24]
3. Robert Koch Institute. Federal health monitoring: expenditures and financing of health care in Germany [in German]. Berlin: Robert Koch Institute, 2009: 45
4. Danzon PM, Furukawa MF. International prices and availability of pharmaceuticals in 2005. Health Aff (Millwood) 2008 Jan-Feb; 27 (1): 221-33 (Pubitemid 351198606)
5. Schwabe U. German drug dispensing report [in German]. In: Schwabe U, Paffrath D, editors. Arzneiverordnungs: report 2010. Berlin: Springer, 2010: 18-27
6. Organisation for Economic Co-operation and Development, Institut de Recherche et d-Etude en Economie de la Santé (IRDES). OECD health data 2010: statistics and indicators. Paris: OECD, 2010
7. German Federal Ministry of Justice. German social security code V [in German; online]. Available from URL: http://www. sozialgesetzbuch-sgb.de/sgbv/1. html [Accessed 2011 May 3]
8. Müller A. AOK: rebate contracts 2010 Sep 20 [in German; online]. Available from URL: http://www.apothekeadhoc.de/Nachrichten/Politik/12050.html [Accessed 2011 Feb 24]
9. Lauer Taxe. Lauer Taxe online [online]. Available from URL: http://taxe.lauer-fischer.de/Taxe/taxe.aspx [Accessed 2011 Apr 17]
10. Federal Joint Committee. 2011 Feb 2 [online]. Available from URL: http://www.g-ba.de/institution/sys/english/ [Accessed 2011 Feb 24]
11. Institute for Quality and Efficiency in Health Care. General methods for the assessment of the relation of benefits to costs. Version 1.0; 2009 Nov 19. Cologne: IQWiG, 2009
12. Australian Government Department of Health and Ageing. Pharmaceutical Benefits Advisory Committee (PBAC) [online]. Available from URL: http://www.health.gov. au/internet/main/publishing.nsf/content/health-pbs- generallisting- committee3.htm [Accessed 2011 Feb 24]
13. Patented Medicine Prices Review Board (PMPRB) [online]. Available from URL: http://www.pmprb-cepmb.gc.ca/ english/View.asp?x=175&mp=87 [Accessed 2011 Feb 24]
14. Department of Health; Medicines, Pharmacy and Industry Group. A new value-based approach to the pricing of branded medicines: a consultation [online]. Available from URL: http://www.dh.gov.uk/prod-consum-dh/groups/dh- digitalassets/@dh/@en/documents/digitalasset/dh-122793. pdf [Accessed 2011 Feb 24]
15. Scottish Medicines Consortium (SMC). Remit [online]. Available from URL: http://www.scottishmedicines.org. uk/About-SMC/What-we-do/Remit [Accessed 2011 Feb 24]
16. Federal Minister of Health. Bylaw to the early benefit assessment of drugs according to §35a SGB V for reimbursement agreements/arrangements according to § 130b SGB V. 2010 Dec 28 [in German]. Bundesgesetzblatt 2010; 1 (68): 2324-8
17. Statutory Health Insurance Fund. Tasks and goals [online]. Available from URL: http://www.gkv-spitzenverband.de/ Tasks-and-goals.gkvnet [Accessed 2011 Feb 24]
18. Office of Fair Trading. The pharmaceutical price regulation scheme: an OFT market study. London: OFT, 2007 Feb [online]. Available from URL: http://www.oft.gov.uk/ shared-oft/reports/comp-policy/oft885.pdf [Accessed 2011 Feb 24]
19. Federal Ministry of Justice. German drug law [in German; online]. Available from URL: http://www.gesetze-iminternet. de/englisch-amg/medicinal- products-act.pdf [Accessed 2011 Feb 24]
20. German Welfare Society. Stellungnahme zum Gesetzentwurf der Fraktionen der CDU/CSU und FDP. Entwurf eines Gesetzes zur Neuordnung des Arzneimittelmarktes in der gesetzlichen Krankenversicherung (Arzneimittelmarktneuordnungsgesetz-AMNOG) [online]. Available from URL: http://www.sovd.de/fileadmin/downloads/sozpol-dok/pdf/sovd-stellungnahme-AMNOG. pdf [Accessed 2011 Feb 24]